Literature DB >> 16932053

Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits.

Kaven Baessler1, Christopher F Maher.   

Abstract

PURPOSE OF REVIEW: Synthetic meshes are increasingly used in the surgical management of stress urinary incontinence and pelvic-organ prolapse in an attempt to improve success rates and increase the longevity of repairs. This review describes and analyses complications following pelvic-floor procedures employing synthetic meshes. RECENT
FINDINGS: Type I monofilament polypropylene mesh with a large pore size is currently the mesh of choice. Chronic inflammation is a typical host response, whereas acute inflammation and predominant CD20+ lymphocyte infiltration represent an adverse host reaction and may result in defective healing. Mesh properties influence the performance and complication rate. Mesh-related complications after midurethral slings and mesh sacrocolpopexies with monofilament polypropylene are rare. An up to 26% mesh erosion rate and up to 38% dyspareunia rate with vaginally introduced mesh for pelvic-organ prolapse repair has been reported. Concurrent hysterectomy seems to increase mesh erosion rates.
SUMMARY: Surgeons should be aware of the potential complications of synthetic meshes. Until data on the safety and efficacy of synthetic mesh in vaginal reconstructive surgery emerge, its routine use outside of clinical trials cannot be recommended.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932053     DOI: 10.1097/01.gco.0000242961.48114.b0

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  26 in total

1.  New approach in vaginal prolapse repair: mini-invasive surgery associated with application of platelet-rich fibrin.

Authors:  Franco Gorlero; Matilde Glorio; Paola Lorenzi; Massimiliano Bruno-Franco; Clemente Mazzei
Journal:  Int Urogynecol J       Date:  2012-01-25       Impact factor: 2.894

Review 2.  Severe cystocele: optimizing results.

Authors:  Jennifer T Anger; Shlomo Raz; Larissa V Rodríguez
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

3.  Laparoscopic sacrocolpopexy for uterine and post-hysterectomy prolapse: anatomical results, quality of life and perioperative outcome-a prospective study with 101 cases.

Authors:  Dimitri Sarlos; Sonja Brandner; LaVonne Kots; Nicolle Gygax; Gabriel Schaer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-07

4.  Short-term outcome after transvaginal mesh repair of pelvic organ prolapse.

Authors:  Daniel Altman; Tapio Väyrynen; Marie Ellström Engh; Susanne Axelsen; Christian Falconer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

5.  Biomechanical properties of raw meshes used in pelvic floor reconstruction.

Authors:  Hannah Krause; Michael Bennett; Mark Forwood; Judith Goh
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-02

Review 6.  Review of synthetic mesh-related complications in pelvic floor reconstructive surgery.

Authors:  Abdulmalik Bako; Ruchika Dhar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-09-09

7.  Long-term results of vaginal repairs with and without xenograft reinforcement.

Authors:  Lone Mouritsen; Manuela Kronschnabl; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2009-12-09       Impact factor: 2.894

Review 8.  The role of synthetic and biologic materials in the treatment of pelvic organ prolapse.

Authors:  Ramon A Brown; C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2014-12

9.  Nitric oxide coating polypropylene mesh increases angiogenesis and reduces inflammatory response and apoptosis.

Authors:  Alessandro Prudente; Wágner José Favaro; Leonardo Oliveira Reis; Cássio Luis Zanettini Riccetto
Journal:  Int Urol Nephrol       Date:  2017-02-08       Impact factor: 2.370

10.  Complications of grafts used in female pelvic floor reconstruction: Mesh erosion and extrusion.

Authors:  Tanya M Nazemi; Kathleen C Kobashi
Journal:  Indian J Urol       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.